Forward Look Back to School Pediatric oncology providers vary in their recommendations on school attendance. by Melinda Mahaffey Icden Life After Pediatric Brain Cancer Survivors of pediatric brain or spinal cord tumors can have cognitive and physical impairments. Researchers say that these deficits can be minimized with the right interventions. by Cheryl Platzman Weinstock Forward Look New Program Helps Families Navigate Pediatric Cancer Patient navigators break down barriers to care and support services. by Christina Bennett Challenges Remain for Kids With Cancer More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments. by Cameron Walker Forward Look Getting to the Root of Brain Cancer Q&A with neurosurgeon Peter Dirks on stem cells and brain cancer. by Chris Palmer Forward Look Childhood Cancer Survivors at Risk for Hormone Deficiencies New study highlights importance of survivorship care. by Sharon Reynolds Caregiving With Confidence On the Path to Adulthood Help your child or teenager with cancer grow and thrive. by Ide Mills Get Involved! The Power of Helping Twelve-year-old cancer survivor Peter Zucca starts a foundation to give back to kids with cancer. by Leigh Labrie Life and Health After Childhood Cancer Survival for children with cancer has improved dramatically, but longer life has revealed long-term health concerns. by Sharon Reynolds New Insights Into Pediatric Cancer A recent discovery may help explain tumor growth in children. by Sue Rochman next Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts